Page 2 - Diabetes

Datanomics: Over 6% of India's population is living with diabetes

World Diabetes Day spotlights India's 89.8 million cases, top testing states, and need for early diagnosis, prevention, and continuous care

One in six Indians now has diabetes, shows new ICICI Lombard wellness study

As diabetes rises to one in six Indians and Gen Z struggles across all wellness pillars, a new study highlights how stress, inactivity and sugar-heavy diets are reshaping the nation's health

WHO issues new guidelines to improve care for diabetes in pregnancy

With diabetes complicating millions of pregnancies each year, the WHO outlines new global guidance on diet, monitoring and treatment to improve safety for mothers and babies

Childhood high blood sugar is rising fast. Here's how to stop it early

Paediatric experts say childhood high blood sugar is driven more by lifestyle than genes, sharing early signs and simple daily habits families can use to prevent long-term glucose problems

Diabetes on the rise: World diabetes day 2025 pushes for early care

With diabetes impacting families across the globe, World Diabetes Day 2025 focuses on raising awareness, encouraging prevention and strengthening access to timely care.

Scrolling your phone before sleep? It may be raising your blood sugar

World diabetes day 2025: Doctors warn that late-night scrolling can suppress melatonin, disrupt sleep cycles, raise cortisol, impair glucose control, creating cravings and metabolic strain over time

Abbott launches new 'Ensure Diabetes Care' to help manage blood sugar

Abbott, a global healthcare company, on Thursday announced the launch of a new and advanced formulation of 'Ensure Diabetes Care' in India. Building on over 30 years of pioneering scientific nutrition and supported by more than 60 clinical trials, the innovation empowers people with diabetes to live a better life, it said in a statement. The new design features a triple care system with vital nutrients, including four times higher myo-inositol compared to the previous formulation, a low glycaemic index carbohydrate blend, which is designed to help minimise blood sugar spikes. Combined with high protein and high fibre, the nutrients work together to support blood sugar control, help reduce cholesterol, and aid in weight management, the US-based healthcare company said. The formulation also helps preserve lean muscle during weight loss, while significantly reducing overall body fat, including visceral fat -- stored deep in the belly around organs like the liver and pancreas -- which is

What is glycaemic index and how it helps you make healthier food choices?

Ahead of World Diabetes Day 2025, experts say GI awareness supports better glucose control and smarter meal planning

Ten diabetes-friendly grains to steady blood sugar and support weight loss

World Diabetes Day 2025: Experts say shifting from high-GI staples to low-GI grains can help steady blood sugar, curb cravings, improve satiety, and support weight control with simple grain rotation

Eli Lilly's Mounjaro tops India pharma charts with ₹100 crore sales in Oct

Mounjaro is part of a new generation of weight-loss and diabetes drugs that target metabolic hormones. Introduced in March, it was launched ahead of rival Novo Nordisk's Wegovy

Diwali sugar spike? Here's how to manage sugar without missing the sweets

Diwali's festive feasts can spell trouble for blood sugar, but they don't have to. Nutritionists share simple swaps, mindful eating tips and portion tricks for safe indulgence.

Biocon Biologics expands Civica tie-up to launch pvt-label insulin in US

The move aims to increase the availability of affordable insulin for the country's 38.4 million diabetes patient

All carbs, little protein: How rice, roti, sugar are hurting India's health

ICMR survey shows 62 per cent of Indian calories come from carbs, linking rice, roti and sugar to rising diabetes, obesity and why adding more protein could reverse the trend

Astronauts with diabetes may soon travel safely to space, finds study

Astronauts with diabetes may soon be able to undertake space missions safely, a study conducted during Shubhanshu Shukla's travel to the International Space Station has found. The Suite Ride experiment, conducted by UAE-based healthcare firm Burjeel Holdings during the Axiom-4 mission, found that everyday diabetes tools used by millions on Earth can be used comprehensively to provide end-to-end diabetes monitoring from space to ground and back to space. "This historic advancement opens the door to future astronauts with diabetes and provides new solutions in remote healthcare," a statement from Burjeel Holdings said. The results of the study were announced at the Burjeel Institute for Global Health, New York, in the presence of Shamsheer Vayalil, founder of Burjeel Holdings and Tejpaul Bhatia, CEO, Axiom Space. As per the research results, continuous glucose monitors (CGMs), a wearable medical device tracking blood sugar levels in real time, and insulin pens can operate reliably in

Small steps, big impact: WHO's 'Best Buys' to fight deadly NCDs worldwide

A new WHO report urges governments around the world to adopt low-cost, high-impact steps to curb heart disease, cancer, diabetes and more, warning that delay will cost lives and strain economies

Why brushing at night may be the cheapest way to cut long-term health risks

Doctors warn that skipping your nightly brush may silently fuel diabetes, heart disease, and chronic inflammation-here's why two minutes before bed could change your health trajectory

Cannabis use may quadruple diabetes risk within five years, warns study

A massive study of over 4 million adults finds cannabis users face fourfold risk of type 2 diabetes within five years, raising new questions on its safety profile

It's not just cancer: Smoking may trigger all types of type-2 diabetes

From insulin resistance to insulin deficiency, smoking raises the risk of every type-2 diabetes form - and the more you smoke, the worse it gets, says new study

Undiagnosed diabetes poses major global health risk, warns new study

A global study reveals that millions go undiagnosed with diabetes. Researchers call for better education, early screening, and affordable treatment access

Nearly 44% of diabetics undiagnosed in 2023, India sees 14% rise: Study

About 44 per cent of the world's diabetics were undiagnosed in 2023, while underdiagnosis and sub-optimal management of glycaemic index continue to pose major challenges in low- and middle-income countries, according to an analysis. Estimates published in The Lancet Diabetes and Endocrinology journal show that 43.6 per cent of India's diabetic population were diagnosed with the condition in 2023, an increase of about 14 per cent in diagnosis rates seen in 2000. Over 97 per cent of those diagnosed were under treatment in 2023, an international team of researchers forming the 'Global Burden of Disease' (GBD) study found. More than 55 per cent of people aged 15 and above around the world were diagnosed with diabetes, the analysis of data collected during 2000-2023 from across 204 countries and territories revealed. "By 2050, 1.3 billion people are expected to be living with diabetes, and if nearly half don't know they have a serious and potentially deadly health condition, it could ..